At the news
? NEUTRALIMPACT 3/10 8-K filed Feb 26, 2026 at 06:02 ET
Soleno Therapeutics announced the retirement of CFO James Mackaness and the appointment of Jennifer Fulk as incoming CFO, effective March 2, 2026. Fulk will receive a $525,000 base salary and equity awards totaling 106,860 shares. Mackaness will transition to a consulting role through year-end.
- Jennifer Fulk appointed CFO effective March 2, 2026
- James Mackaness retiring, will serve as consultant through December 31, 2026
- Fulk's compensation: $525,000 base salary, 67,660 stock options, 39,200 RSUs
- Fulk previously CFO at Talkspace and held executive roles at Eli Lilly
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access